Evidence map›Paper›PMID 33755090›Full record

ArticleBlood advances2021

Azacitidine maintenance after allogeneic hematopoietic cell transplantation for MDS and AML.

Firas El Chaer, Uma Borate, Rémy Duléry, Shernan G Holtan, Arjun Datt Law, Lori Muffly, Samah Nassereddine, Rory M Shallis, Kate Stringaris, Justin Taylor and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Firas El ChaerDivision of Hematology/Oncology, University of Virginia, Charlottesville, VA.
Uma BorateDivision of Hematology, James Cancer Center, The Ohio State University, Columbus, OH.
Rémy DuléryService d'Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint Antoine, Sorbonne Université, INSERM UMRS 938, Paris, France.
Shernan G HoltanDivision of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN.
Arjun Datt LawDivision of Medical Oncology and Hematology, University Health Network, Toronto, ON, Canada.
Lori MufflyDivision of Blood and Marrow Transplantation, Stanford University, Palo Alto, CA.
Samah NassereddineDivision of Hematology and Oncology, George Washington University Cancer Center, Washington, DC.
Rory M ShallisSection of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.
Kate StringarisNational Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
Justin TaylorDivision of Hematology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL; and.
Steven M DevineNational Marrow Donor Program/Be The Match and Center for International Blood and Marrow Transplant Research, Minneapolis, MN.
Mohamad MohtyService d'Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint Antoine, Sorbonne Université, INSERM UMRS 938, Paris, France.
Christopher S HouriganNational Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.

Funding

Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.ZIAHL006163 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI HOURIGAN, CHRISTOPHER · 2013 to 2023
$21.0M
Intramural NIH HHS ZIA HL006163
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hematopoietic Stem Cell TransplantationLeukemia, Myeloid, AcuteAzacitidineHumansTransplantation, HomologousAzacitidine

Identifiers

PMID33755090
PMCPMC7993104

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.